Pictet Asset Management (Switzerland)’s Immunogen Inc IMGN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$13.6M	Buy	721,075 +695,266	+2,694%	+$8.21M	0.02%	554
2023 Q1	$99.1K	Hold	25,809	–	–	﹤0.01%	1872
2022 Q4	$128K	Buy	25,809 +9,709	+60%	+$52.6K	﹤0.01%	1818
2022 Q3	$77K	Hold	16,100	–	–	﹤0.01%	1493
2022 Q2	$73K	Hold	16,100	–	–	﹤0.01%	1513
2022 Q1	$77K	Hold	16,100	–	–	﹤0.01%	1632
2021 Q4	$119K	Hold	16,100	–	–	﹤0.01%	1642
2021 Q3	$91K	Buy	+16,100	New	+$93K	﹤0.01%	1695

Other funds holding IMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IMGN Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Immunogen Inc (IMGN) stake by 2,694% in Q2 2023, buying an estimated $8.21M and bringing the position to 721,075 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #554.

Pictet Asset Management (Switzerland) first reported a position in IMGN in Q3 2021 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

Pictet Asset Management (Switzerland) held 721,075 shares of Immunogen Inc worth $13.6M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 695,266 Immunogen Inc shares in Q2 2023, an estimated $8.21M.
Immunogen Inc made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #554 holding.
Pictet Asset Management (Switzerland) first reported a position in Immunogen Inc in Q3 2021 and has held it in 8 quarters since.
266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.